{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:02:29Z","timestamp":1781650949612,"version":"3.54.5"},"reference-count":23,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1995,6]]},"abstract":"<jats:p>Ursodeoxycholic acid (UDCA) leads to biochemical and clinical improvement in many patients with primary biliary cirrhosis (PBC); although, the response is variable. This study compared UDCA treated patients with complete normalisation of biochemical functions to those without such improvement. Of the 65 patients receiving UDCA, 12 (19%) showed normalisation of liver biochemical functions at two years. The remaining 53 patients showed a less complete response. Mean (SD) alkaline phosphatase and total serum bilirubin values were significantly lower at entry in the patients whose liver biochemistry tests normalised (912 (732) U\/l v 1417 (1021) U\/l, p = 0.003, and 0.7 (12.1 (5.2) mumol\/l v 38.9 (48.5) mumol\/l, p = 0.0002, respectively), and percentage of UDCA in biliary bile acid was higher (56.3 (9.5)% v 38.3 (21.1)%, p = 0.03). Patients with biochemically and histologically less severe disease, and greater enrichment of biliary bile with UDCA, are more likely to respond favourably to the drug. The main objective of continued study will be to find out if normal liver biochemical functions can retard disease progression. The association of greater UDCA enrichment with complete biochemical responses suggests that higher doses of UDCA should be evaluated.<\/jats:p>","DOI":"10.1136\/gut.36.6.935","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"935-938","source":"Crossref","is-referenced-by-count":66,"title":["Characterisation of patients with a complete biochemical response to ursodeoxycholic acid."],"prefix":"10.1136","volume":"36","author":[{"given":"R A","family":"Jorgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K D","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1995,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM198702263160907","article-title":"Primary biliary cirrhosis","volume":"316","author":"Kaplan, M.M.","year":"1987","unstructured":"Kaplan MM. Primary biliary cirrhosis. N EnglJ Med 1987; 316: 521-8.","journal-title":"N EnglJ Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon, R.E.; Balkau, B.; Eschwege, E.; Poupon, R.","year":"1991","unstructured":"Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.","journal-title":"N Engl J Med"},{"key":"ref_3","first-page":"861","article-title":"Sulfated and unsulfated bile acids in serum, bile, and urine of patients with cholestasis","volume-title":"Gut","volume":"17","author":"GP, Van Berge Henegouwen; KH, Brandt; H, Eyssen; G, Parmentier","year":"1976","unstructured":"Van Berge Henegouwen GP, Brandt KH, Eyssen H, Parmentier G. Sulfated and unsulfated bile acids in serum, bile, and urine of patients with cholestasis. Gut 1976; 17: 861-9."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840120308","article-title":"Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis","volume":"12","author":"Stiehl, A.; Rudolph, G.; Raedsch, R.; Moller, B.; Hopf, U.; Lotterer, E.","year":"1990","unstructured":"Stiehl A, Rudolph G, Raedsch R, Moller B, Hopf U, Lotterer E, et al. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 1990; 12: 492-7.","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840120307","article-title":"Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes","volume":"12","author":"Galle, P.R.; Theilmann, L.; Raedsch, R.; Otto, G.; Stiehl, A.","year":"1990","unstructured":"Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990; 12: 486-91.","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa, M.; Tsujii, T.; Matsumura, K.; Yamao, J.; Matsumura, Y.; Kubo, R.","year":"1992","unstructured":"Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992; 16: 358-64.","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner, U.; Fischer, H.; Kurtz, W.; Guldutuna, S.; Hubner, K.; Hellstern, A.","year":"1989","unstructured":"Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989; 97: 1268-74.","journal-title":"Gastroenterology"},{"key":"ref_8","first-page":"1221","article-title":"Ursodeoxycholic acid improves liver function and reduces serum and urinary endogenous bile acids in primary biliary cirrhosis","volume":"8","author":"Batta, A.K.; Arora, R.; Salen, G.; Katz, S.","year":"1988","unstructured":"Batta AK, Arora R, Salen G, Katz S. Ursodeoxycholic acid improves liver function and reduces serum and urinary endogenous bile acids in primary biliary cirrhosis. Hepatology 1988; 8: 1221.","journal-title":"Hepatology"},{"key":"ref_9","first-page":"1421","article-title":"A randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis (PBC)","volume":"8","author":"Hadziyannis, S.; Hadziyannis, E.","year":"1988","unstructured":"Hadziyannis S, Hadziyannis E. A randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis (PBC) [Abstract]. Hepatology 1988; 8: 1421.","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig, J.; Dickson, E.R.; McDonald, G.S.A.","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GSA. Staging of chronic nonsuppurative cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A 1978; 379: 103-12.","journal-title":"Virchows Arch A"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-2275(20)38684-3","article-title":"High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids","volume":"28","author":"Rossi, S.S.; Converse, J.L.; Hofmann, A.F.","year":"1987","unstructured":"Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. Jf Lipid Res 1987; 28: 589-95.","journal-title":"Jf Lipid Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor, K.D.; Dickson, E.R.; Baldus, W.P.; Jorgensen, R.A.; Ludwig, J.; Murtaugh, P.A.; et ad","year":"1994","unstructured":"Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, et ad. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-90.","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1172\/JCI115601","article-title":"Physiochemical and physiological properties of cholylsarcosine: a potential replacement detergent for bile acid deficiency states in the small intestine","volume":"89","author":"Lillienau, J.; Schteingart, C.D.; Hofman, A.F.","year":"1992","unstructured":"Lillienau J, Schteingart CD, Hofman AF. Physiochemical and physiological properties of cholylsarcosine: a potential replacement detergent for bile acid deficiency states in the small intestine. Jf Clin Invest 1992; 89: 420-31.","journal-title":"Jf Clin Invest"},{"key":"ref_14","first-page":"1641","article-title":"Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile","volume-title":"secretion in rats. Gastroenterology 1992; 103","author":"Heuman, D.M.; Vlahcevic, Z.R.; Pandak, W.M.; Hylemon, P.B.; Kim, Y.S.; Lillienau, J.","unstructured":"Heuman DM, Vlahcevic ZR, Pandak WM, Hylemon PB, Kim YS, Lillienau J, et al. Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats. Gastroenterology 1992; 103: 1641-8."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis of primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson, E.R.; Grambsch, P.M.; Fleming, T.R.; Fisher, L.D.; Langworthy, A.","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis of primary biliary cirrhosis: model for decision making. Hepatology 1989; 10: 1-7.","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0270-9139(93)92404-N","article-title":"Can ursodeoxycholic acid monotherapy induce disease remission in primary biliary cirrhosis?","volume":"18","author":"Wolfhagen, F.H.J.; van Buuren, H.R.; van Berge Henegouwen, G.P.; van Hattum, J.; Eskens, F.; Kerbert-Dreteler, M.J.","year":"1993","unstructured":"Wolfhagen FHJ, van Buuren HR, van Berge Henegouwen GP, van Hattum J, Eskens F, Kerbert-Dreteler MJ, et al. Can ursodeoxycholic acid monotherapy induce disease remission in primary biliary cirrhosis? Hepatology 1993; 18: 220A.","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson, E.R.; Fleming, T.R.; Wiesner, R.H.; Baldus, W.P.; Fleming, C.R.; Ludwig, J.","year":"1985","unstructured":"Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, et al. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl Jf Med 1985; 312: 1011-5.","journal-title":"N Engl Jf Med"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger, J.; Christensen, E.; Portmann, B.; Caballeria, J.; Rodes, J.; Ranek, L.","year":"1985","unstructured":"Neuberger J, Christensen E, Portmann B, Caballeria J, Rodes J, Ranek L, et al. Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. Gut 1985; 26: 114-9.","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff, D.S.; Alpert, E.; Resnick, R.H.; Kaplan, M.M.","year":"1982","unstructured":"Matloff DS, Alpert E, Resnick RH, Kaplan MM. A prospective trial of D-penicillamine in primary biliary cirrhosis. N EngltJMed 1982; 306: 319-26.","journal-title":"N EngltJMed"},{"key":"ref_20","first-page":"124","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"96","author":"HC, Jr, Bodenheimer; F, Schaffner; J, Pezullo","year":"1988","unstructured":"Bodenheimer HC Jr, Schaffner F, Pezullo J. Evaluation of colchicine therapy in primary biliary cirrhosis. Gastroenterology 1988; 96: 124-9.","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan, M.M.; Alling, D.W.; Zimmerman, H.J.; Wolfe, H.J.; Sepersky, R.A.; Hirsch, G.S.","year":"1986","unstructured":"Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, et al. A prospective trial of colchicine for primary biliary cirrhosis. N Engl Jf Med 1986; 315: 1448-54.","journal-title":"N Engl Jf Med"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle, J.H.; Davis, G.L.; Schafer, D.F.; Peters, M.; Avigan, M.I.; Pappas, S.C.","year":"1986","unstructured":"Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, et al. Randomized trial of chlorambucil for primary biliary cirrhosis. Gastroenterology 1986; 91: 1327-34.","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner, R.H.; Ludwig, J.; Lindor, K.D.; Jorgensen, R.A.; Baldus, W.P.; Homburger, H.A.","year":"1990","unstructured":"Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP, Homburger HA, et al. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. NEnglJMed 1990; 322: 1419-24.","journal-title":"NEnglJMed"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.36.6.935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:55:28Z","timestamp":1765616128000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.36.6.935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1995,6,1]]},"published-print":{"date-parts":[[1995,6]]}},"alternative-id":["10.1136\/gut.36.6.935"],"URL":"https:\/\/doi.org\/10.1136\/gut.36.6.935","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}